Prot #GS-US-432-4097: A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis

Project: Research project

Project Details

StatusFinished
Effective start/end date10/24/1710/24/23

Funding

  • PPD Development (Prot #GS-US-432-4097 // Prot #GS-US-432-4097)
  • Gilead Sciences, Inc (Prot #GS-US-432-4097 // Prot #GS-US-432-4097)